Outcomes among racial and ethnic minority patients with advanced cancers in phase 1 trials: a meta-analysis (vol 7, e2421485, 2024)

被引：0

作者：

Goel, Sanjay

Negassa, Abdissa

Ghalib, Mohammad H.

Chaudhary, Imran

Desai, Kavita

Shah, Umang

Swami, Umang

Cohen, Bruce

Maitra, Radhashree

Mani, Sridhar

机构：

来源：

JAMA NETWORK OPEN | 2024年 / 7卷 / 08期

关键词：

D O I：

10.1001/jamanetworkopen.2024.33744

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：1

共 35 条

[11] Comparative Efficacy and Safety of Programmed Death-1 Pathway Inhibitors in Advanced Gastroesophageal Cancers: A Systematic Review and Network Meta-Analysis of Phase III Clinical Trials
da Silva, Laercio Lopes
Aguiar, Pedro Nazareth, Jr.
Park, Robin
Edelman Saul, Eduardo
Haaland, Benjamin
de Lima Lopes, Gilberto
CANCERS, 2021, 13 (11)
[12] The Role of SGLT2 Inhibitors on Heart Failure Outcomes in Nondiabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (vol 83, pg 158, 2024)
Kommu, S.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2024, 83 (04) : 359 - 359
[13] Efficacy and safety of PD-1 inhibitors as first- and second- line treatments for advanced gastroesophageal cancers: A network meta-analysis of phase III clinical trials.
Da Silva, Laercio Lopes
Park, Robin
Aguiar, Pedro Nazareth
Saul, Eduardo Edleman
Haaland, Benjamin
Lopes, Gilberto
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[14] Pulmonary Toxicities of Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials (vol 95, e3008, 2016)
Hong, D.
Zhang, G.
Zhang, X.
MEDICINE, 2016, 95 (30)
[15] Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials (vol 7, pg 776, 2019)
Kristensen, S. L.
Rorth, R.
Jhund, P. S.
LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (03): : E2 - E2
[16] Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients: A Systematic Review and Meta-analysis (vol 6, e2250416, 2023)
Vince Jr, R. A.
Jiang, R.
Bank, M.
JAMA NETWORK OPEN, 2023, 6 (02)
[17] Comparison of Effectiveness Among Different Sodium-Glucose Cotransporter-2 Inhibitors According to Underlying Conditions: A Network Meta-Analysis of Randomized Controlled Trials (vol 13, e031805, 2024)
Kani, Ryoma
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (06):
[18] Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials
Rivera, Frederick Berro
Bantayan, Nathan Ross B.
Aparece, John Paul
Cruz, Linnaeus Louisse A.
Magallong, John Vincent
Pine, Polyn Luz
Idian-Javier, Anne Mira Nicca
Lumbang, Grace Nooriza O.
Lerma, Edgar, V
Lara-Breitinger, Kyla M.
Gulati, Martha
Vijayaraghavan, Krishnaswami
JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (04) : e588 - e601
[19] Pancreatitis and Pancreatic Cancer Risk Among Patients With Type 2 Diabetes Receiving Dipeptidyl Peptidase 4 Inhibitors: An Updated Meta-Analysis of Randomized Controlled Trials (vol 46, pg 650,2024)
Tuersun, Adili
Hou, Guanxin
Cheng, Gang
CLINICAL THERAPEUTICS, 2025, 47 (01)
[20] Clinical benefits of PD-1 inhibitors in specific subgroups of patients with advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of phase 3 randomized clinical trials
Lu, Yao
Wang, Wenkang
Wang, Feng
FRONTIERS IN IMMUNOLOGY, 2023, 14

← 1 2 3 4 →